Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Site Complication”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00853125
What this trial is testing

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 10
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Not applicableStudy completedNCT04692961
What this trial is testing

Change in the Lower Leg Muscle Stiffness Following Peroneal Artery-based Flap

Who this might be right for
Donor Site ComplicationMuscle; Ischemic
National Taiwan University Hospital 9
Testing effectiveness (Phase 2)Study completedNCT01539980
What this trial is testing

Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment

Who this might be right for
Late Complication From Skin GraftInfection of Skin Donor SiteImpaired Wound Healing+1 more
Chulalongkorn University 30
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Not applicableStudy completedNCT04422925
What this trial is testing

S100β, NSE n GFAP in Living Donor Hepatectomy and Delirium

Who this might be right for
Donor Site ComplicationDeliriumUremic Encephalopathy+1 more
Akdeniz University 56
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Not applicableUnknownNCT04997863
What this trial is testing

Clinical Efficacy and Safety of Sericin Hydrogel Sheet Impregnated With Bird's Nest Extract

Who this might be right for
WoundDonor Site ComplicationSkin Graft Scar+1 more
Chulalongkorn University 30
Large-scale testing (Phase 3)UnknownNCT05990049
What this trial is testing

Hyaluronic Acid and Free Gingival Graft Healing

Who this might be right for
Hyaluronic AcidGingival Recession, LocalizedPain, Postoperative
University of Zagreb 40
Testing effectiveness (Phase 2)UnknownNCT04186273
What this trial is testing

Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.

Who this might be right for
ScarCicatrixHypertrophic Scar+4 more
University of British Columbia 50
Testing effectiveness (Phase 2)Study completedNCT00923845
What this trial is testing

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Who this might be right for
Renal Cell CarcinomaGraft-Versus-Host DiseaseEngraftment Syndrome
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT04050124
What this trial is testing

Impact of Prisma on Donor Site Pain

Who this might be right for
Skin Graft DisorderDonor Site Complication
NYU Langone Health 17
Not applicableEnded earlyNCT04014400
What this trial is testing

Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites

Who this might be right for
BurnsSkin Graft ComplicationsSkin; Deformity
University of Colorado, Denver 10
Not applicableStudy completedNCT01670201
What this trial is testing

An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients

Who this might be right for
Donor Site Complication
Molnlycke Health Care AB 8
Not applicableUnknownNCT06030791
What this trial is testing

BTB Graft Harvest and Donor Site Morbidity After ACL Reconstruction

Who this might be right for
Anterior Cruciate Ligament RuptureDonor Site Complication
Clinical Center of Vojvodina 60
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Post-approval studies (Phase 4)WithdrawnNCT02994589
What this trial is testing

A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites

Who this might be right for
Skin Graft Complications
Loma Linda University
Testing effectiveness (Phase 2)Ended earlyNCT01925118
What this trial is testing

Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2

Who this might be right for
Metastatic Malignant Melanoma and Renal Cell Carcinoma
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Next Page